DNMT1 regulates human endometrial carcinoma cell proliferation

Area of Science:

• Gynecologic Oncology
• Molecular Biology
• Epigenetics

Background:

• Endometrial carcinoma (EC) is the most common gynecologic malignancy.
• The molecular mechanisms driving EC development and progression are not fully understood.
• DNA methyltransferases play crucial roles in epigenetic regulation, but their specific involvement in EC requires further investigation.

Purpose of the Study:

• To investigate the role of DNA methyltransferase 1 (DNMT1) in endometrial carcinoma (EC).
• To determine the effects of DNMT1 inhibition on EC cell behavior and molecular pathways.

Main Methods:

• AN3CA human EC cells were transfected with DNMT1 siRNA to achieve gene knockdown.
• Cell proliferation was assessed using the Cell Counting Kit-8 (CCK-8) assay.
• Cell cycle distribution and apoptosis were analyzed by flow cytometry.
• Gene expression levels of apoptosis- and cell cycle-associated proteins were quantified using polymerase chain reaction (PCR) and Western blot analysis.

Main Results:

• Knockdown of DNMT1 significantly inhibited AN3CA cell proliferation.
• DNMT1 inhibition induced apoptosis and caused G0/G1 phase arrest in EC cells.
• DNMT1 knockdown led to upregulation of nuclear factor kappa-B-inhibitor alpha (NF-κBIA) and Bax, while downregulating Bcl-2 and CCND1/2 expression.

Conclusions:

• This study provides the first evidence that DNMT1 plays a critical role in EC cell proliferation and apoptosis.
• Downregulation of DNMT1 impacts the expression of key cell cycle and apoptosis-associated proteins in EC cells.
• DNMT1 inhibition presents a potential therapeutic strategy for endometrial carcinoma.